Partnership between Scitara and Veeva to bring optimised QC lab productivity to customers
Scitara and Veeva have announced a partnership to bring improved data infrastructures to the quality control process of drug and therapeutic market release.
Cloud-based laboratory software solutions provider Scitara (Marlborough, USA) have announced their partnership with life sciences cloud-computing specialists Veeva (Pleasanton, USA) to improve data integrity in the lab and maximise productivity.
Scitara will bring its scientific integration platform, SIP, and digital lab exchange DLX to complement Veeva Vault LIMS (laboratory information management system) working to streamline sample tracking, test execution, and lab processes for the optimisation of real-time batch release. The integration of Veeva Vault LIMS with Scitara’s platforms will address potential bottlenecks in the quality control of drug and therapeutic manufacturing. Customers will be provided with connected and compliant workflows, removing manual and paper-based processes and reducing the need for a second-person review. These processes will reduce the quality control timeline and accelerate the market release of a drug or therapeutic.
Scitara CEO and founder Ajit Nagral commented: “The evolution of the lab depends on a single integrated ecosystem. The same fundamental principles apply, whether handling data from the lab or manufacturing processes. Scitara’s SIP provides a core infrastructure that establishes a dialogue across all controlling systems that guide the laboratory workflow: instruments, LIMS, e-notebooks, and manufacturing execution systems as well as the way scientists and researchers exchange data too.”
Jason Boyd, Senior Director, Veeva Vault LIMS strategy, added: “Life sciences companies are striving to take control of data, gain a greater degree of accountability to regulatory health authorities, and streamline working practices. Bringing benchtop data from instruments and applications securely into Veeva Vault LIMS in real-time will eliminate the need for point-to-point integrations or manual data entry. This is critical for enabling data-driven decisions.”
Source: Scitara and Veeva partner to help companies optimize QC lab productivity - Scitara Corporation
Related News
-
News On Track at Pharmapack 2024 - The Track Sponsor interview: BD Pharmaceuticals
January 2024 brings both a new year and Europe’s leading packaging and drug delivery event. Bringing the world’s experts in pharmaceutical packaging together in Paris, France, Pharmapack 2024 brings exciting opportunities to learn and colla... -
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News Roche breaks into the obesity drug market with the acquisition of Carmot Therapeutics
In a bid to diversify their therapeutic offerings, Roche takes over Carmot Therapeutics in $2.7 billion deal, with one obesity drug spearheading the venture into the field as they prep for a Phase II in-human trial. -
News Biden backs Cold-War measures to shore-up medical supply chains
In a recent strategy to combat rising inflation and the cost of living crisis, President Joe Biden has invoked a Cold War-era act to increase investment in a selection of medicines and supplies. -
News Women in Pharma: Delivering solutions for gender diversity
In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona Speaker Interview – What the US FDA’s Quality Management Maturity Means for the Pharma Industry
At CPHI Barcelona (24–26 October, 2023), we spoke to Sireesha Yadlapalli, CEO of Pharmatech Associates, who gave a presentation on the implications of the US FDA’s Quality Management Maturity (QMM) Initiative, and spoke on the panel of the ... -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News Wegovy and weight-loss drugs driving demand for manufacturers that can fill syringes
Injectable weight-loss treatments are prompting contract manufacturers to invest and include fill-finish services into their service portfolios, in a bid to attract pharmaceutical giants developing drugs similar to Novo Nordisk's Wegovy.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance